[ad_1] Listen to this article EValuate Diagnostics, the first spinout company from Hackensack Meridian Health’s Research Institute and its Office of Innovation and Commercialization, received a $1 million commitment from Foundation Venture Capital Group (FVCG). Announced last week, EValuate Diagnostics offers a new platform for the targeted capture of circulating biomarkers, or extracellular vesicles (EVs).…

Read more